Seven Fleet Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Seven Fleet Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.17M	Sell	11,869 -310	-3%	-$72.4K	0.52%	33
2026 Q1	$2.79M	Buy	12,179 +6,509	+115%	+$1.46M	0.88%	30
2025 Q4	$1.21M	Buy	+5,670	New	+$1.17M	0.82%	21

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Seven Fleet Capital Management's ASND Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Ascendis Pharma A/S (ASND) stake by 2.5% in Q2 2026, selling an estimated $72.4K and leaving 11,869 shares worth $3.17M. The position accounts for 0.52% of the portfolio, ranked #33.

Seven Fleet Capital Management first reported a position in ASND in Q4 2025 and has held it in 3 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Seven Fleet Capital Management held 11,869 shares of Ascendis Pharma A/S worth $3.17M as of Q2 2026.
Seven Fleet Capital Management sold 310 Ascendis Pharma A/S shares in Q2 2026, an estimated $72.4K.
Ascendis Pharma A/S made up 0.52% of Seven Fleet Capital Management's portfolio in Q2 2026, its #33 holding.
Seven Fleet Capital Management first reported a position in Ascendis Pharma A/S in Q4 2025 and has held it in 3 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.